The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors August 17, 2016
Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration August 16, 2016
The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving August 11, 2016
Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study August 8, 2016
